These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3494679)

  • 1. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation.
    Hänsch GM; Seitz M; Betz M
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):317-20. PubMed ID: 3494679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane B2 synthesis in human platelets induced by the late complement components C5b-9.
    Betz M; Seitz M; Hänsch GM
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):313-6. PubMed ID: 2437045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components.
    Hänsch GM; Seitz M; Martinotti G; Betz M; Rauterberg EW; Gemsa D
    J Immunol; 1984 Oct; 133(4):2145-50. PubMed ID: 6432907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPS-stimulated release of prostaglandin E and thromboxane B2 from the U937 cell line.
    Schenkein HA
    Cell Immunol; 1986 Oct; 102(2):307-14. PubMed ID: 3100058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of the reacylation of liberated arachidonic acid.
    Hänsch GM; Gemsa D; Resch K
    J Immunol; 1985 Aug; 135(2):1320-4. PubMed ID: 2409145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-bound C3b stimulates human monocyte release of prostaglandin E and thromboxane B2.
    Fulford DE; Rutherford RB
    J Leukoc Biol; 1987 Apr; 41(4):363-6. PubMed ID: 2952748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9.
    Schönermark M; Deppisch R; Riedasch G; Rother K; Hänsch GM
    Int Arch Allergy Appl Immunol; 1991; 96(4):331-7. PubMed ID: 1809690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the late complement components C5b-9 and of platelet-derived growth factor on the prostaglandin release of human synovial fibroblast-like cells.
    von Kempis J; Torbohm I; Schönermark M; Jahn B; Seitz M; Hänsch GM
    Int Arch Allergy Appl Immunol; 1989; 90(3):248-55. PubMed ID: 2512262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2, prostaglandin E1 and thromboxane B2 release from human monocytes treated with C3b or bacterial lipopolysaccharide.
    Nichols FC; Schenkein HA; Rutherford RB
    Biochim Biophys Acta; 1987 Feb; 927(2):149-57. PubMed ID: 3101743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells.
    Torbohm I; Schönermark M; Wingen AM; Berger B; Rother K; Hänsch GM
    Kidney Int; 1990 Apr; 37(4):1098-104. PubMed ID: 2342248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement membrane attack complex stimulates the prostanoid production of cultured glomerular epithelial cells.
    Hänsch GM; Betz M; Günther J; Rother KO; Sterzel B
    Int Arch Allergy Appl Immunol; 1988; 85(1):87-93. PubMed ID: 3123397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma potentiation of lipopolysaccharide-induced eicosanoid release from human monocytes.
    Nichols FC; Garrison SW
    J Interferon Res; 1987 Feb; 7(1):121-9. PubMed ID: 3108416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E and thromboxane B2 release by PMA-induced U937 cells in response to C3b.
    Schenkein HA
    J Leukoc Biol; 1986 May; 39(5):511-9. PubMed ID: 3457882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal nocturnal hemoglobinuria. Enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane.
    Blaas P; Berger B; Weber S; Peter HH; Hänsch GM
    J Immunol; 1988 May; 140(9):3045-51. PubMed ID: 3361126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of serum on C3b-stimulated release of prostaglandins and thromboxane B2 from human monocytes.
    Schenkein HA; Rutherford RB
    Immunopharmacology; 1984 Oct; 8(2):79-89. PubMed ID: 6511367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement.
    Betz M; Haensch GM; Rauterberg EW; Bommer J; Ritz E
    Kidney Int; 1988 Jul; 34(1):67-73. PubMed ID: 3139906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon blocks interleukin 1-induced prostaglandin release from human peripheral monocytes.
    Browning JL; Ribolini A
    J Immunol; 1987 May; 138(9):2857-63. PubMed ID: 3106491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3-mediated release of prostaglandin from human monocytes. Behaviour in short-term culture.
    Schenkein HA; Rutherford B
    Immunology; 1984 Jan; 51(1):83-91. PubMed ID: 6690398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 and thromboxane B2 release from human monocytes treated with bacterial lipopolysaccharide.
    Nichols FC; Garrison SW; Davis HW
    J Leukoc Biol; 1988 Nov; 44(5):376-84. PubMed ID: 3141540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of glomerular mesangial cells by the terminal membrane attack complex of complement.
    Lovett DH; Haensch GM; Goppelt M; Resch K; Gemsa D
    J Immunol; 1987 Apr; 138(8):2473-80. PubMed ID: 3494069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.